Atopic Dermatitis: Optimizing Outcomes

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

On-demand Webinar with Patient Decision Simulation

Faculty Presenter

Johnathan I Silverberg, MD, PhD, MPH
Director, Northwestern Medicine Multidisciplinary Eczema Center
Director, Contact Dermatitis Clinic, Northwestern Memorial Hospital
Assistant Professor, Departments of Dermatology, Preventive Medicine, and Medical Social Sciences
Northwestern University Feinberg School of Medicine
Chicago, IL

Program Overview

Identified gaps indicate a need to educate health care providers in the diagnosis, treatment and management of atopic dermatitis (AD). This CME/CE program provides information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can helps guide treatment selection. Expert faculty will discuss guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes. This activity will provide HCPs with the practical skills necessary to educate patients in self-care, thereby reducing relapses and enhancing their health-related quality of life.

Educational

Upon completion of this free educational activity, participants will be able to:
  • Explain the pathophysiology, signs and symptoms, and diagnostic criteria of atopic dermatitis.
  • Design individualized treatment plans for adults with moderate-to-severe AD based on current guideline recommendations for AD, the safety and efficacy of new and emerging treatment options, comorbidities, and patient quality of life
  • Diagnose AD in adult patients based on the evaluation of clinical characteristics specific to the adult patient population
  • Examine communication and education strategies to improve adherence to AD treatment strategies and assess the effects of treatment on patient quality of life
Target Audience: Dermatologists, primary care physicians, nurse practitioners, physician assistants, and all other healthcare professionals involved in the care and treatment of patients with atopic dermatitis (AD)

How to Obtain Credit

To receive credit, participants must complete the online pre-assessment questions, view the webinar in its entirety, and complete the decision simulation and activity evaluation form. Once this is done, participants can request their credit.
 
This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians' Education Resource®, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



AANP

Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is accredited for 1.25 contact hour(s) which includes 00 hour(s) of pharmacology. Activity ID # 2336E.
 
This activity was planned in accordance with AANP CE Standards and Policies.
 
Release date: October 19, 2017
Expiration date: October 19, 2018
 
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Disclosures

Faculty
Jonathan Silverberg, MD, PhD, MPH disclosed the following relationships with commercial interests:
  • Grant/Research Support: AbbVie, Celgene, Chugai, GlaxoSmithKline, Lilly, PuriCore, Roche-Hoffmann, Regeneron-Sanofi
  • Consultant: AbbVie, Anacor, Galderma, GlaxoSmithKline, Lilly, Medimmune-AstraZeneca, Pfizer, Procter & Gamble, PuriCore, Regeneron-Sanofi
  • Speaker's Bureau: Regeneron-Sanofi
The following contributors have no relevant financial relationships with commercial interests to disclose.
 
Physicians' Education Resource®, LLC (PER®)
Planning Staff—David Heckard; Maryjo Dixon, RPh, Jyoti Arya, RPh; and Kate Bowen.
 
Global Education Group
Kristen Delisi, NP, Lindsay Borvansky, Ashely Marostica, RN, MSN, Andrea Funk, Lindsay Knight

Activity Disclaimer

Global Education Group and Physicians' Education Resource®, LLC (PER®) strive to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars. PER® reserves the right to cancel an event without notice and is not be responsible for any expenditure incurred due to the cancellation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Physicians' Education Resource®, LLC do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

System Requirements

PC-based participants
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based participants
Required: Mac OS® X 10.4.11 (Tiger®) or newer
 
For questions about this Internet CPE activity, please contact: ceinfo@permedical.com
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com
Privacy Policy www.gotoper.com/privacy






Become a Member

Forgot Password?
Filter By